Cargando…
Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma
The peripheral T-cell lymphomas are a rare and heterogeneous group of mature T-cell lymphomas with limited available therapies. The outcome of frontline chemotherapy regimens has been disappointing, with a long-term survival of only 20%–30%. There is an urgent need to optimize induction therapy by i...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216035/ https://www.ncbi.nlm.nih.gov/pubmed/25368524 http://dx.doi.org/10.2147/OTT.S59269 |